All News

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:

Links:
Measureable Benefits to Treat-to-Target Management in RA
Desai and colleagues have published that when a learning collaborative group focused on a treat‐to‐target approach was compared to usual care, a modest but significant impact on implementation, treatment changes and patient outcomes in RA patients managed with a treat‐to‐target approach was seen.
Read Article
Links:

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:

Links:

Links:

Links:

Links:

Links:
Dr. John Cush RheumNow ( View Tweet)

Elena MyasoedovaMD MyasoedovaElena ( View Tweet)
RWCS Highlights - Day 3
Day 3 report from the 2021 RWCS meeting in Maui (and virtually) includes pearls from the PsA 2020 Year in Review; fact vs. fiction on evidence based medicine: diet and rheumatic diseases; hot topics in allergy/immunology; and pediatric rheumatology highlights.
Read Article
Links:
Dr. John Cush RheumNow ( View Tweet)


Weekly Semaglutide for Weight Loss in Adults
NEJM has reported the results of a trial showing semaglutide once weekly plus lifestyle intervention was associated with sustained, weight loss in overweight or obese adults; such that nearly one-third lost over 20% of their body weight.
Read Article